Modelled cost-effectiveness evaluation of bipolar disorder treatments to guide health policy
Version 2 2024-06-03, 19:23
Version 1 2015-01-01, 00:00
conference contribution
posted on 2024-06-03, 19:23 authored by ML Chatterton, Cathy MihalopoulosCathy Mihalopoulos, J Barendregt, Michael BerkMichael Berk, PB Mitchell, J Khoo, Rob CarterRob CarterThis analysis evaluates the cost-effectiveness of acute and
maintenance treatments for bipolar disorder (I and II) to assist in
efficient allocation of resources to reduce the burden of this condition.
History
Related Materials
- 1.
Location
Toronto, CanadaLanguage
engPublication classification
E3.1 Extract of paperCopyright notice
2015, WileyEditor/Contributor(s)
[Unknown]Volume
17Pagination
52-52Start date
2015-06-03End date
2015-06-06ISSN
1398-5647Title of proceedings
ISBD 2015 : Proceedings of the International Society for Bipolar Disorders 2015 Annual ConferenceEvent
International Society for Bipolar Disorders. Annual Conference (17th : 2015 : Toronto, Canada)Publisher
WileyPlace of publication
London, Eng.Series
Supplement 1Usage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPsychiatryNeurosciences & NeurologySchool of Medicine920410 Mental HealthSchool of Health and Social Development111799 Public Health and Health Services not elsewhere classified111714 Mental Health140208 Health Economics920207 Health Policy Economic Outcomes110999 Neurosciences not elsewhere classifiedFaculty of HealthInnovation in Mental and Physical Health and Clinical Treatment420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC